Mobilization and recruitment of endothelial progenitor cells (EPC) contributes to
vasculogenesis in vivo. So far, applications for cell therapy are limited by the number of …

Background—Transplantation of ex vivo expanded circulating endothelial progenitor cells
(EPCs) from peripheral blood mononuclear cells improves the neovascularization after …

Background Endothelial progenitor cells (EPCs) were shown to have angiogenic potential
contributing to neovascularization. However, a clear definition of mouse EPCs by cell …

Background—We investigated the therapeutic potential of ex vivo expanded endothelial
progenitor cells (EPCs) for myocardial neovascularization. Methods and Results …

Endothelial progenitor cells (EPCs) seem to be a promising tool for cell therapy of acute
myocardial infarction, but their nature is still unclear. We show here that EPCs obtainable …

Background—Endothelial progenitor cells (EPCs) circulate in adult peripheral blood (PB)
and contribute to neovascularization. However, little is known regarding whether EPCs and …

The replacement of endothelium by endothelial progenitor cells (EPCs) for therapeutic use
in order to ameliorate the vascular status of ischemic organs is now in the focus of vascular …

The field of cell‐based transplantation has expanded considerably and is poised to become
an established cardiovascular therapy in the near future. In this review, we will focus on …

The mobilization of endothelial progenitor cells (EPCs) into circulation from bone marrow is
well known to be present in several clinical settings, including acute coronary syndrome …

A decade of research has sought to identify circulating endothelial progenitor cells (EPC) in
order to harness their potential for cardiovascular regeneration. Endothelial outgrowth cells …